Home About Programs Publications News Meetings Contact
Boards of pharmacy Members Pharmacists Students Technicians Government affairs Consumers
Menu Nabp-logo
Icon-eprofile e-Profile Login and ID Quick Search
Home About Programs Publications News Meetings Contact
Boards of pharmacy Members Pharmacists Students Technicians Government affairs Consumers

FDA Warns Consumers about Counterfeit Alli

January 18, 2010 6:42 PM Topics: Internet pharmacy

The US Food and Drug Administration is today warning consumers about a counterfeit and potentially harmful version of Alli 60 mg capsules (120 count refill kit). Read the FDA news release for more information.

 

  • Mexico's Shadow Pharma Market
  • Fake Drugs Bought on the Web Pose Big Health Risks
Sign up to receive NABP e-News Sign up to receive AWARxE News

News Topics

  • Compounding
  • Controlled substances
  • Counterfeit drugs
  • Buying medicine online
  • Committee and task force reports
  • Continuing education
  • Diversion
  • Education
  • Electronic prescriptions
  • Federal regulations
  • Internet pharmacy
  • Medication collection program disposal
  • Over the counter
  • Patient safety
  • Pharmacies
  • Pharmacists
  • Pharmacy technicians
  • Practitioner prescriber
  • Prescribing authority
  • Prescription drug abuse
  • Prescription label
  • Prescription monitoring program
  • Prescriptions
  • Pseudoephedrine
  • Resolutions
  • Tamper resistant prescription
  • Vaccinations

Archives

  • October 2013 (7)
  • September 2013 (21)
  • August 2013 (22)
  • July 2013 (25)
  • June 2013 (28)
  • May 2013 (40)
  • April 2013 (27)
  • March 2013 (21)
  • February 2013 (20)
  • January 2013 (26)
  • 2012 (303)
  • 2011 (359)
  • 2010 (301)
  • 2009 (189)
  • 2008 (188)
  • 2007 (215)
  • 2006 (164)
  • 2005 (53)
  • 2004 (62)
  • 2003 (43)
  • 2002 (37)
  • 2001 (31)

Copyright © 2013 National Association of Boards of Pharmacy® (NABP®).

  • Resources
  • Terms of Use Statement
  • Privacy Policy
  • Linking Policy
NABP